This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Cosette Pharmaceuticals, Inc. The deal strengthens Cosettes dermatology and womens health businesses, expands Cosettes commercial and operational capabilities, and adds multiple sustainable and growing patent-protected products. The post Cosette Pharmaceuticals Acquires Mayne Pharma appeared first on The Dermatology Digest.
The Sustainable Beauty E-Summit happened over on our Discord on March 6th, 2022. Introduction by Jen Novakovich Presentation 1: Sustainability in Packaging by packaging technologist, Dan Coppins. Scouting the latest trends and products over the world with sustainability in mind. This blog is a replay of the whole e-summit!
is introducing Act4Impact 2030, a new sustainability strategy. Initiatives to achieve these goals include energy decarbonization, sustainable mobility. The company will roll out sustainable procurement programs and engage suppliers in its Net Zero Supplier Engagement initiative. Almirall S.A.
So far we’ve hosted a sustainability conference in March. His current focus is on Sun care, Color cosmetics and Sustainable innovation. In the meantime, she completed her doctoral studies at the University of Basel in Pharmaceutical Sciences in 2015. The Sunscreen E-Summit is part of our greater e-conference series.
Oftentimes, they can instead be attributed to the efficiency of production, and sustainability. There are a lot of factors that make these “naturals” more expensive, such as supply issues for the many botanicals that are currently wild-harvested - which is actually a pretty big sustainability threat (2,3). Poechlauer, P., Am Ende, D.,
GLP-1’s unique ability to affect both glucose metabolism and appetite makes it a critical hormone in weight management and a target for pharmaceutical treatments aimed at curbing hunger and improving metabolic health. GLP-1 helps counteract this effect by maintaining appetite control and sustaining weight loss over the long term.
So far we’ve hosted a sustainability conference in March, as well as a collab conference with Michelle @labmuffinbeautyscience on sunscreen in May. Dr M has over 20 years of experience in the pharmaceutical, biopharma and cosmetics industries. This was our attempt to democratize accurate information for the cosmetics industry.
Her work has been featured in international publications including New York Times and Chemical & Engineering News John's Slides John Stanton comes from a background of 60 years of experience in the pharmaceutical and health care industries, mostly spent in R & D related roles.
They are working with a pharmaceutical company to find compounds which inhibit an enzyme called lysol oxidase or LOX. They claims the product is “extremely biodegradable” which doesn’t tell us very much. See when a scar is formed, this enzyme causes collagen molecules to form chemical bonds within themselves which leads to scar formation.
Both drugs come from the Danish pharmaceutical company Novo Nordisk, whose market capitalization has soared to $609 billion, surpassing Tesla’s valuation by $40 billion. Leading this trend is semaglutide, better known by its brand names Ozempic, a diabetes medication, and Wegovy, a higher-dose variant specifically for weight loss.
Using natural, sustainable science-backed ingredients, the products address common challenges and triggers related to reactive skin and inflammatory conditions. Why you’ll love it: For even the most ultra-sensitive skin, Hale & Hush delivers serious soothing and calming. Why you’ll love it: Beautiful results with no downtime.
However, it can interfere with some medications, including oral chemotherapy, high blood pressure medications, blood thinners, cholesterol medications, immunosuppressive drugs, and pharmaceutical diabetes treatments ( US News ). Women who are pregnant or breastfeeding should avoid berberine.
Robert Kushner of Northwestern University, who serves on Novo Nordisk’s advisory board, told NPR, “This hormone is telling your brain, I'm full, I don't need to eat anymore … What the pharmaceutical companies have done is taken this hormone that is naturally occurring and restructured it into a drug.”
However, it can interfere with some medications, including oral chemotherapy, high blood pressure medications, blood thinners, cholesterol medications, immunosuppressive drugs, and pharmaceutical diabetes treatments. There are also newer sustained release preparations. Women who are pregnant or breastfeeding should avoid berberine.
Additionally, Magnolia dealbata , an endangered species from Mexico, also contains honokiolhighlighting the importance of biodiversity conservation for pharmaceutical innovation. It doesn’t merely suppress bacterial load; it interrupts the inflammatory cascade driving comedogenesis and pustule formation.
They act as signaling molecules that initiate and sustain the various phases of cell metabolism necessary for healing. Dr. Vincent works closely with major pharmaceutical companies in the field as a Global Advisor and lectures internationally. He is also on the judging panel for Miss Universe Great Britain.
The first was that the pharmaceutical industry and the FDA recently signaled that drugs for obesity will become the new market investors can expect excellent returns from (this will be discussed in an upcoming article). Recently, two things made me realize I nonetheless needed to cover this subject.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content